Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Telemed J E Health ; 18(6): 434-45, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22694296

RESUMO

OBJECTIVES: To offer a systematic review of the body of literature in the emerging field of telemedicine in the management of acute-phase injuries. MATERIALS AND METHODS: We conducted a literature review. RESULTS: Telemedicine has only recently been applied to the specialties of trauma, emergency care, and surgery. The potential benefits of telemedicine include a decrease in travel expenses, enhanced continuity of care, and increased access to specialized consultants in medically underserved and rural areas. CONCLUSIONS: There still exist barriers to the use of teletechnologies in medicine that limit their wider adoption. Poor infrastructure, limited equipment availability, and insufficient access to training and education for medical personnel have prevented wider use.


Assuntos
Padrões de Prática Médica , Telemedicina/organização & administração , Ferimentos e Lesões/prevenção & controle , Doença Aguda , Continuidade da Assistência ao Paciente , Sistemas de Informação Hospitalar , Humanos , Prognóstico , Telemedicina/métodos , Estados Unidos
2.
ASN Neuro ; 3(3): e00060, 2011 Jun 07.
Artigo em Inglês | MEDLINE | ID: mdl-21542802

RESUMO

HD (Huntington's disease) is characterized by dysfunction and death of striatal MSNs (medium-sized spiny neurons). Excitotoxicity, transcriptional dysregulation and mitochondrial abnormalities are among the mechanisms that are proposed to play roles in HD pathogenesis. To determine the extent of cell-autonomous effects of mhtt (mutant huntingtin) protein on vulnerability to excitotoxic insult in MSNs in vivo, we measured the number of degenerating neurons in response to intrastriatal injection of QA (quinolinic acid) in presymptomatic and symptomatic transgenic (D9-N171-98Q, also known as DE5) mice that express mhtt in MSNs but not in cortex. After QA, the number of degenerating neurons in presymptomatic DE5 mice was not significantly different from the number in WT (wild-type) controls, suggesting the early, increased vulnerability to excitotoxicity demonstrated in other HD mouse models has a largely non-cell-autonomous component. Conversely, symptomatic DE5 mice showed significantly fewer degenerating neurons relative to WT, implying the resistance to excitotoxicity observed at later ages has a primarily cell-autonomous origin. Interestingly, mitochondrial complex II respiration was enhanced in striatum of symptomatic mice, whereas it was reduced in presymptomatic mice, both relative to their age-matched controls. Consistent with the QA data, MSNs from symptomatic mice showed decreased NMDA (N-methyl-d-aspartate) currents compared with age-matched controls, suggesting that in addition to aging, cell-autonomous mechanisms mitigate susceptibility to excitotoxicity in the symptomatic stage. Also, symptomatic DE5 mice did not display some of the electrophysiological alterations present in other HD models, suggesting that blocking the expression of mhtt in cortical neurons may restore corticostriatal function in HD.


Assuntos
Envelhecimento/fisiologia , Corpo Estriado/fisiologia , Mitocôndrias/metabolismo , Proteínas do Tecido Nervoso/metabolismo , Proteínas Nucleares/metabolismo , Prosencéfalo/fisiologia , Animais , Corpo Estriado/citologia , Corpo Estriado/efeitos dos fármacos , Corpo Estriado/patologia , Modelos Animais de Doenças , Complexo de Proteínas da Cadeia de Transporte de Elétrons/metabolismo , Complexo II de Transporte de Elétrons/fisiologia , Eletrofisiologia , Proteína Huntingtina , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Mitocôndrias/efeitos dos fármacos , N-Metilaspartato/metabolismo , Proteínas do Tecido Nervoso/genética , Neurônios/metabolismo , Neurônios/patologia , Proteínas Nucleares/genética , Prosencéfalo/anatomia & histologia , Prosencéfalo/efeitos dos fármacos , Prosencéfalo/patologia , Ácido Quinolínico/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA